Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen E Rodgers

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Current Opinion in Molecular Therapeutics|June 28, 2005
Technology evaluation: Chrysalin (Orthologic)Kathleen E Rodgers
Frontiers in Neuroscience|June 7, 2024
Advancements and challenges in amyotrophic lateral sclerosisDavid Bradford, Kathleen E Rodgers
Frontiers in Endocrinology|October 30, 2013
Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic TargetKathleen E Rodgers, Gere S Dizerega
Frontiers in Aging Neuroscience|December 16, 2022
Analysis of shared underlying mechanism in neurodegenerative diseaseRickeem Butler, David Bradford, Kathleen E Rodgers
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 10, 2020
Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infectionMaira Soto, Gere diZerega, Kathleen E Rodgers
Frontiers in Immunology|January 11, 2020
Improving the Innate Immune Response in Diabetes by Modifying the Renin Angiotensin SystemMaira Soto, Kevin J Gaffney, Kathleen E Rodgers
Cancer Chemotherapy and Pharmacology|August 13, 2005
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancerKathleen E Rodgers, Jamie Oliver, Gere S diZerega
Cancer Chemotherapy and Pharmacology|April 27, 2002
Accelerated recovery from irradiation injury by angiotensin peptidesKathleen E Rodgers, Shiquin Xiong, Gere S diZerega
Frontiers in Immunology|August 15, 2020
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL<i>-lpr</i> MiceMaira Soto, Nicole Delatorre, Chelsie Hurst, et al.
The American Journal of Medicine|December 10, 2022
Renin-Angiotensin System-Modifying Antihypertensive Drugs Can Reduce the Risk of Cardiovascular Complications in Lupus: A Retrospective Cohort StudyChelsie Hurst, Maira Soto, Ernest R Vina, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Current Opinion in Molecular Therapeutics|June 28, 2005
Technology evaluation: Chrysalin (Orthologic)Kathleen E Rodgers
Frontiers in Neuroscience|June 7, 2024
Advancements and challenges in amyotrophic lateral sclerosisDavid Bradford, Kathleen E Rodgers
Frontiers in Endocrinology|October 30, 2013
Contribution of the Local RAS to Hematopoietic Function: A Novel Therapeutic TargetKathleen E Rodgers, Gere S Dizerega
Frontiers in Aging Neuroscience|December 16, 2022
Analysis of shared underlying mechanism in neurodegenerative diseaseRickeem Butler, David Bradford, Kathleen E Rodgers
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|November 10, 2020
Countermeasure and therapeutic: A(1-7) to treat acute respiratory distress syndrome due to COVID-19 infectionMaira Soto, Gere diZerega, Kathleen E Rodgers
Frontiers in Immunology|January 11, 2020
Improving the Innate Immune Response in Diabetes by Modifying the Renin Angiotensin SystemMaira Soto, Kevin J Gaffney, Kathleen E Rodgers
Cancer Chemotherapy and Pharmacology|August 13, 2005
Phase I/II dose escalation study of angiotensin 1-7 [A(1-7)] administered before and after chemotherapy in patients with newly diagnosed breast cancerKathleen E Rodgers, Jamie Oliver, Gere S diZerega
Cancer Chemotherapy and Pharmacology|April 27, 2002
Accelerated recovery from irradiation injury by angiotensin peptidesKathleen E Rodgers, Shiquin Xiong, Gere S diZerega
Frontiers in Immunology|August 15, 2020
Targeting the Protective Arm of the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL<i>-lpr</i> MiceMaira Soto, Nicole Delatorre, Chelsie Hurst, et al.
The American Journal of Medicine|December 10, 2022
Renin-Angiotensin System-Modifying Antihypertensive Drugs Can Reduce the Risk of Cardiovascular Complications in Lupus: A Retrospective Cohort StudyChelsie Hurst, Maira Soto, Ernest R Vina, et al.
Pageof 6